- Aspira Women's Health Inc. (AWH, Financial) will change its trading symbol from 'AWH' to 'AWHL', effective April 17, 2025.
- The company's shares will transition from NASDAQ to OTC Markets, indicating a shift in their trading platform.
- Aspira Women's Health specializes in diagnostic tools for gynecologic diseases.
Aspira Women's Health Inc. (NASDAQ:AWH), a leading bio-analytical company renowned for its expertise in women's health, has announced a forthcoming change in its trading symbol. Effective April 17, 2025, the company's common stock will commence trading under the new symbol "AWHL" on the OTC Markets Group platforms. This change marks the transition from its previous trading under the "AWH" symbol on NASDAQ.
Aspira Women's Health is at the forefront of innovation in the field of gynecologic disease diagnostics. Key offerings from the company include OvaSuiteSM, encompassing OvaWatch® and Ova1Plus®, which are utilized to evaluate ovarian cancer risk. The company continues to push boundaries with its in-development test pipeline aimed at tackling diseases such as endometriosis. Aspira is focused on enhancing its diagnostic tools by integrating microRNA and protein biomarkers with patient data to advance the accuracy and reliability of its tests.
With its shift to OTC Markets, Aspira continues to emphasize its dedication to transforming the landscape of women's health diagnostics, despite potential implications for liquidity and institutional involvement due to the change in trading venue.
